{"TopicDetails": {"type": 0, "ccm2Id": 43364776, "cftId": 0, "identifier": "ISFP-2020-AG-DRUGS", "title": "ISFP-2020-AG-DRUGS", "publicationDateLong": 1604534400000, "callIdentifier": "ISFP-2020-AG-DRUGS", "callTitle": "Call for proposals on better law enforcement in the area of illicit drug trafficking, in particular of cocaine", "callccm2Id": 43364787, "allowPartnerSearch": true, "workProgrammepart": {"id": 280550, "ccm_id": 43061086, "wp_part": "ISFP-2020", "wp_year": "ISFP-2020", "wp_title": "Internal Security Fund Police", "wp_website": "http://ec.europa.eu/dgs/home-affairs/financing/fundings/security-and-safeguarding-liberties/internal-security-fund-police/index_en.htm", "wp_document": "https://ec.europa.eu/home-affairs/sites/default/files/3rd_revised_annual_work_programme_isf_police_2020.pdf"}, "frameworkProgramme": {"id": 31077817, "abbreviation": "ISFP", "description": "Internal Security Fund Police"}, "programmeDivision": [{"id": 31077813, "abbreviation": "ISFP-1-6", "description": "Drugs"}, {"id": 31077807, "abbreviation": "ISFP-1", "description": "Police cooperation"}], "topicMGAs": [], "tags": ["cocaine", "drug trafficking", "drug", "illicit"], "sme": false, "actions": [{"status": {"id": 31094503, "abbreviation": "Closed", "description": "Closed"}, "types": [{"typeOfAction": "ISFP-AG ISF-Police Action Grant", "typeOfMGA": []}], "plannedOpeningDate": "05 November 2020", "submissionProcedure": {"id": 31094504, "abbreviation": "single-stage", "description": "single-stage"}, "deadlineDates": ["18 March 2021"]}], "latestInfos": [], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3349415": [{"action": "ISFP-2020-AG-DRUGS - ISFP-AG ISF-Police Action Grant", "plannedOpeningDate": "05 November 2020", "deadlineModel": "single-stage", "deadlineDates": ["18 March 2021"], "budgetYearMap": {"2020": 2500000}, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["2020"]}, "description": "<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p><span>The present Call for Proposals aims at funding projects on better law enforcement in the area of illicit drug trafficking.</span></p><p><span> </span></p>\n", "conditions": "<p><b><span style=\"font-size:9.0pt;line-height:115%;&#10;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&quot;Times New Roman&quot;;&#10;color:#003366;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:&#10;AR-SA\">1.&nbsp;&nbsp; Eligible countries: </span></b></p>\r\n<p><span style=\"font-size:10.0pt;font-family:&quot;Verdana&quot;,sans-serif;mso-fareast-language:&#10;FR-BE\">The Member States of the European Union with exception of Denmark (&ldquo;Member States participating in the ISF Police instrument&rdquo;).</span></p>\r\n<p><span style=\"font-size:10.0pt;font-family:&quot;Verdana&quot;,sans-serif;mso-fareast-language:&#10;FR-BE\">Third countries: Albania, Bosnia and Herzegovina, The Republic of North Macedonia, Kosovo, Montenegro and Serbia - in duly justified cases where their participation is necessary to achieve the objectives of the project and only as co-applicants.</span></p>\r\n<p><span style=\"font-size:9.0pt;&#10;line-height:115%;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&quot;Times New Roman&quot;;&#10;color:black;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:&#10;AR-SA\"> </span></p>\r\n<p><span style=\"font-size:10.0pt;font-family:&quot;Verdana&quot;,sans-serif\">International organisations may participate only as co-applicants and may be established outside the Member States participating in the ISF-Police instrument.</span></p>\r\n<p>&nbsp;</p>\r\n<p style=\"margin-top:0cm;margin-right:0cm;margin-bottom:6.0pt;&#10;margin-left:0cm;tab-stops:14.2pt 108.0pt\"><span style=\"font-size:10.0pt;&#10;font-family:&quot;Verdana&quot;,sans-serif\">The lead applicant must be established in a</span><span style=\"font-size:10.0pt;font-family:&quot;Verdana&quot;,sans-serif;&#10;mso-fareast-language:FR-BE\"> Member State participating in the ISF Police instrument</span><span style=\"font-size:10.0pt;font-family:&quot;Verdana&quot;,sans-serif\">.</span></p>\r\n<p><span style=\"font-size:10.0pt;&#10;font-family:&quot;Verdana&quot;,sans-serif\">For UK applicants: Please note that the United Kingdom is not bound by Regulation (EU) No&nbsp;513/2014 establishing the ISF Police instrument and its implementing decisions and UK entities are therefore not eligible to participate under this call.</span></p>\r\n<p>&nbsp;</p>\r\n<div style=\"mso-element:footnote-list\">&nbsp;</div>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\n<p><b><span style=\"font-size:9.0pt;line-height:115%;&#10;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&quot;Times New Roman&quot;;&#10;color:#003366;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:&#10;AR-SA\">2.&nbsp;&nbsp; Eligibility and admissibility conditions:</span></b><span style=\"font-size:9.0pt;line-height:115%;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;&#10;mso-fareast-font-family:&quot;Times New Roman&quot;;color:black;mso-ansi-language:EN-GB;&#10;mso-fareast-language:EN-GB;mso-bidi-language:AR-SA\"> described in sections 5 and 6 of the <a href=\"https://ec.europa.eu/research/participants/data/ref/other_eu_prog/home/wp-call/call-fiche_isfp-2020-ag-drugs_en.pdf\" target=\"_blank\">Call document</a>&nbsp;<br />\r\n&nbsp; &nbsp; &nbsp;&nbsp;</span></p>\r\n<p>&nbsp;</p>\n<p><b><span style=\"font-size:9.0pt;line-height:115%;&#10;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&quot;Times New Roman&quot;;&#10;color:#003366;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:&#10;AR-SA\">3.&nbsp;&nbsp; Indicative timetable for evaluation and grant agreement:</span></b><span style=\"font-size:9.0pt;line-height:115%;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;&#10;mso-fareast-font-family:&quot;Times New Roman&quot;;color:black;mso-ansi-language:EN-GB;&#10;mso-fareast-language:EN-GB;mso-bidi-language:AR-SA\"> described in section 3 of the <a href=\"https://ec.europa.eu/research/participants/data/ref/other_eu_prog/home/wp-call/call-fiche_isfp-2020-ag-drugs_en.pdf\" target=\"_blank\">Call document.</a></span></p>\r\n<p>&nbsp;</p>\n<p><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&#10;&quot;Times New Roman&quot;;color:#003366;mso-fareast-language:EN-GB\">4.&nbsp;&nbsp; Proposal templates and model grant agreements (MGA):</span></b></p>\r\n<p>&nbsp;</p>\r\n<p style=\"color: rgb(0, 0, 0); font-family: eui-light,Helvetica Neue,Helvetica,sans-serif; font-size: 12.6px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 1.5; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; padding-bottom: 3px; padding-left: 0px; padding-right: 0px; padding-top: 3px; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;\"><span style=\"color: rgb(0, 51, 102); font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;; font-size: 9pt;\"><span style=\"color: rgb(0, 0, 0);\"><span style=\"color: rgb(0, 51, 102); font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;; font-size: 9pt;\"><span style=\"color: rgb(0, 0, 0);\"><span style=\"color: rgb(0, 51, 102); font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;; font-size: 9pt;\"><span style=\"color: rgb(0, 0, 0);\"><a href=\"https://ec.europa.eu/research/participants/data/ref/other_eu_prog/common/justdrugs-isfp-isfb-amif_guide-applicants-20_en.pdf\" style=\"color: rgb(40, 151, 183); text-decoration: none;\" target=\"_blank\">Guide for applicants</a></span></span></span></span></span></span><span style=\"display: inline !important; float: none; background-color: rgb(198, 219, 239); color: rgb(0, 0, 0); font-family: eui-light,Helvetica Neue,Helvetica,sans-serif; font-size: 12.6px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;\"> </span></p>\r\n<p style=\"color: rgb(0, 0, 0); font-family: eui-light,Helvetica Neue,Helvetica,sans-serif; font-size: 12.6px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 1.5; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; padding-bottom: 3px; padding-left: 0px; padding-right: 0px; padding-top: 3px; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;\"><span style=\"color: rgb(0, 51, 102); font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;; font-size: 9pt;\"><span style=\"color: rgb(0, 0, 0);\"><span style=\"color: rgb(0, 51, 102); font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;; font-size: 9pt;\"><span style=\"color: rgb(0, 0, 0);\"><span style=\"color: rgb(0, 51, 102); font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;; font-size: 9pt;\"><span style=\"color: rgb(0, 0, 0);\"><span style=\"background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); display: inline; float: none; font-family: Arial,Verdana,sans-serif; font-size: 12px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;\"> </span><span style=\"color: rgb(0, 51, 102); font-size: 9pt; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;\"><span style=\"color: rgb(0, 0, 0);\"><a href=\"https://ec.europa.eu/research/participants/data/ref/other_eu_prog/common/tpl/pt/justdrugs-isfp-isfb-amif_call-pt-20_en.pdf\" style=\"color: rgb(40, 151, 183); text-decoration: none;\" target=\"_blank\">Standard proposal template</a></span></span></span></span></span></span></span></span><span style=\"display: inline !important; float: none; background-color: rgb(198, 219, 239); color: rgb(0, 0, 0); font-family: eui-light,Helvetica Neue,Helvetica,sans-serif; font-size: 12.6px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;\"> </span></p>\r\n<p style=\"color: rgb(0, 0, 0); font-family: eui-light,Helvetica Neue,Helvetica,sans-serif; font-size: 12.6px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 1.5; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; padding-bottom: 3px; padding-left: 0px; padding-right: 0px; padding-top: 3px; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;\"><span style=\"color: rgb(0, 51, 102); font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;; font-size: 9pt;\"><span style=\"color: rgb(0, 0, 0);\"><span style=\"color: rgb(0, 51, 102); font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;; font-size: 9pt;\"><span style=\"color: rgb(0, 0, 0);\"><span style=\"color: rgb(0, 51, 102); font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;; font-size: 9pt;\"><span style=\"color: rgb(0, 0, 0);\"><span style=\"color: rgb(0, 0, 255);\"><a href=\"https://ec.europa.eu/research/participants/data/ref/other_eu_prog/common/justdrugs-isfp-isfb-amif_mga-multi_en.pdf\" style=\"color: rgb(40, 151, 183); text-decoration: none;\" target=\"_blank\">M</a></span></span></span></span></span><span style=\"color: rgb(0, 0, 255);\"><a href=\"https://ec.europa.eu/research/participants/data/ref/other_eu_prog/common/justdrugs-isfp-isfb-amif_mga-multi_en.pdf\" style=\"color: rgb(40, 151, 183); text-decoration: none;\" target=\"_blank\">ulti-beneficiary Model Grant Agreement</a></span></span></span></p>\r\n<p><br />\r\n<span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&#10;&quot;Times New Roman&quot;;color:#003366;mso-fareast-language:EN-GB\"><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&#10;&quot;Times New Roman&quot;;color:#003366;mso-fareast-language:EN-GB\"><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&#10;&quot;Times New Roman&quot;;color:#003366;mso-fareast-language:EN-GB\"><span style=\"color: rgb(0, 0, 0);\">&nbsp; &nbsp; &nbsp;<br />\r\n&nbsp;</span></span></span></span><span style=\"color: rgb(0, 0, 255);\"><br />\r\n&nbsp; &nbsp;&nbsp;</span></span></span></p>\n<p>Members of consortium are required to conclude a consortium agreement, in principle prior to the signature of the grant agreement.</p>\n<p><b><span style=\"font-size:9.0pt;line-height:115%;&#10;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&quot;Times New Roman&quot;;&#10;color:#003366;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:&#10;AR-SA\">5.&nbsp;&nbsp; Additional documents:<br />\r\n</span></b><span style=\"font-size:9.0pt;&#10;line-height:115%;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&quot;Times New Roman&quot;;&#10;color:black;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:&#10;AR-SA\"><br />\r\n&nbsp; &nbsp;&nbsp; </span><span style=\"font-size: 11pt; line-height: 115%; font-family: &quot;Calibri&quot;,&quot;sans-serif&quot;;\"><span style=\"font-size: 9pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32018R1046&amp;rid=9\" target=\"_blank\">EU Financial Regulation</a></span></span></p>\r\n<p><span style=\"font-size: 11pt; line-height: 115%; font-family: &quot;Calibri&quot;,&quot;sans-serif&quot;;\"><span style=\"font-size: 9pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;\"> </span></span></p>\r\n<p>&nbsp; &nbsp;&nbsp; <a href=\"http://ec.europa.eu/dgs/home-affairs/financing/fundings/security-and-safeguarding-liberties/internal-security-fund-police/index_en.htm\" style=\"color: rgb(40, 151, 183); font-family: eui-light,Helvetica Neue,Helvetica,sans-serif; font-size: 12.6px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decoration: underline; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;\" target=\"_blank\">ISFP  Website</a></p>\r\n<p>&nbsp; &nbsp;&nbsp; <span style=\"font-family: &amp;quot;Calibri&amp;quot;,&amp;quot;sans-serif&amp;quot;; font-size: 11pt; line-height: 115%;\"><span style=\"font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;; font-size: 9pt; line-height: 115%;\"><a href=\"https://ec.europa.eu/home-affairs/sites/homeaffairs/files/financing/fundings/security-and-safeguarding-liberties/internal-security-fund-police/union-actions/docs/awp_isfp_2020_en.pdf\" style=\"color: rgb(40, 151, 183); text-decoration: none;\" target=\"_blank\">ISF-P Annual Work Programme 2020</a></span></span></p>\r\n<p><span style=\"display: inline !important; float: none; background-color: rgb(198, 219, 239); color: rgb(0, 0, 0); font-family: eui-light,Helvetica Neue,Helvetica,sans-serif; font-size: 12.6px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;\"> </span></p>\r\n<p style=\"color: rgb(0, 0, 0); font-family: eui-light,Helvetica Neue,Helvetica,sans-serif; font-size: 12.6px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 1.5; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; padding-bottom: 3px; padding-left: 0px; padding-right: 0px; padding-top: 3px; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;\"><span style=\"font-family: &amp;quot;Calibri&amp;quot;,&amp;quot;sans-serif&amp;quot;; font-size: 11pt; line-height: 115%;\"><span style=\"font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;; font-size: 9pt; line-height: 115%;\">&nbsp; &nbsp;&nbsp; ISF-P legal basis</span></span><span style=\"color: black; font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;; font-size: 9pt;\">: <a href=\"https://ec.europa.eu/research/participants/data/ref/other_eu_prog/home/legal/isfp-legalbasis_en.pdf\" style=\"color: rgb(40, 151, 183); text-decoration: none;\" target=\"_blank\">Regulation (EU) No 513/2014</a> and <a href=\"https://ec.europa.eu/research/participants/data/ref/other_eu_prog/home/legal/isfp-legalbasis2_en.pdf\" style=\"color: rgb(40, 151, 183); text-decoration: none;\" target=\"_blank\">Regulation (EU) No 514/2014</a></span><span style=\"color: black; font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;; font-size: 9pt;\"><br />\r\n</span></p>\r\n<p><span style=\"display: inline !important; float: none; background-color: rgb(198, 219, 239); color: rgb(0, 0, 0); font-family: eui-light,Helvetica Neue,Helvetica,sans-serif; font-size: 12.6px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;\"> </span></p>\r\n<p style=\"color: rgb(0, 0, 0); font-family: eui-light,Helvetica Neue,Helvetica,sans-serif; font-size: 12.6px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 1.5; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; padding-bottom: 3px; padding-left: 0px; padding-right: 0px; padding-top: 3px; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;\"><span style=\"font-family: &amp;quot;Calibri&amp;quot;,&amp;quot;sans-serif&amp;quot;; font-size: 11pt; line-height: 115%;\"><span style=\"font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;; font-size: 9pt; line-height: 115%;\">&nbsp; &nbsp; &nbsp;</span></span><br />\r\n&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<div>&nbsp;</div>\r\n<p>&nbsp;</p>\r\n<p><br />\r\n&nbsp;</p>", "supportInfo": "<p>Contact the&nbsp;<a href=\"mailto:HOME-ISF@ec.europa.eu\" target=\"_blank\"><strong>HOME-ISF@ec.europa.eu</strong></a> for further assistance related to content of the call and topics.</p>\r\n<p><strong><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/faq;categories=;programme=null;actions=;keyword=\" target=\"_blank\">F&amp;T Portal FAQ</a></strong>&nbsp;&ndash; Submission of proposals.<br />\r\n<br />\r\n<strong><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/helpdesks/contact-form\" target=\"_blank\">IT Helpdesk</a></strong>&nbsp;&ndash; contact the IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.</p>\r\n<p><a href=\"https://ec.europa.eu/research/participants/portal4/desktop/en/funding/guide.html\" target=\"_blank\"><strong>H2020 Online Manual</strong></a> -<strong> Please use the manual with caution and only for the Participant Portal tools guidance</strong>, i.e. Submission service and Beneficiary register. It is H2020 specific and does not cover the ISFP rules. Some aspects of these funds are different from the provisions of the H2020 programme.</p>", "sepTemplate": "<p>To access the Electronic Submission Service, please click on the submission-button next to the type of action that corresponds to your proposal. You will then be asked to confirm your choice of the type of action and topic, as these cannot be changed in the submission system. Upon confirmation, you will be linked to the correct entry point.</p>\r\n<p>To access existing draft proposals for this topic, please login to the Funding &amp; Tenders Portal and select the My Proposals page of the My Area section.</p>", "links": [], "additionalDossiers": [], "infoPackDossiers": [], "callDetailsJSONItem": {"staticAdditionalInfo": "<p>Activities aiming at enhancing cooperation between EU Member States or EU Member Statesand third countries located along drug trafficking routes to and from the EU, in particular by supporting joing initiativeson knowledge , detection, investigation and prosecution of drugs trafficking.</p>\n", "latestInfos": [{"approvalDate": "Nov 5, 2020 12:00:00 AM", "lastChangeDate": "Nov 5, 2020 12:00:00 AM", "content": "The submission session is now available for: ISFP-2020-AG-DRUGS(ISFP-AG)"}], "hasForthcomingTopics": false, "hasOpenTopics": false, "allClosedTopics": true}}}